AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

Webinar: WCG Avoca 2020 Industry Research on Innovation and Diversity

How do we finish what COVID started?


Recorded Thursday, June 17, 2021  |  11:00–12:00 EDT


The COVID pandemic shined a light on two areas of historical weakness in the clinical research industry – a slowness to adopt technology and a lack of proactive planning to ensure clinical trial subject diversity – but also exposed the industry’s potential for tremendous achievements in each of these areas. In this webinar, the first to highlight the 2020 Avoca Industry Research involving representatives from over 150 companies, you will learn about how the events of 2020 accelerated operational and study design innovations within clinical development, how respondents perceived various aspects of clinical trial quality, patient diversity, and efficiency to have been impacted, what drivers and impediments arose, and whether respondents anticipated a “snap back” to pre-innovation approaches and perceptions, or an acceleration of innovation, post-Covid-19. We will also explore respondents’ perceptions of the performance of their own companies, and the industry as a whole, with respect to diversity in clinical trial participation, and with respect to true preparedness for deployment of clinical research innovations. Finally, we will discuss how experiences and perceptions vary across companies within the industry, with a focus on what this tells us about leading practices for success in these areas.


Through this discussion, participants will gain insights regarding:

  • how the events of 2020 affected use of operational and study design innovations in clinical development
  • whether processes “kept up” and how quality, efficiency, and diversity were impacted
  • whether a return to pre-2020 status, or an acceleration of innovation, is anticipated post-COVID-19
  • critical success factors and leading practices for successful adoption of clinical trial innovations




Denise Calaprice, PhD

Senior Consultant

WCG Avoca



Crissy MacDonald, PhD

Vice President, Client Delivery

WCG Avoca



This event is part of Avoca’s 2021 Jon Lee Webinar Series
In tribute to the late Jon Lee, who was an early supporter and one of the first Members of the Avoca Quality Consortium in 2011. Jon was a believer in closing the learning gaps at all levels and often participated in Avoca’s Summits as part of Executive Panels, sharing his experience, and thought leadership. The 2021 quarterly webinar series established in his honor will be focused on sharing knowledge and keeping the clinical trial community connected and informed.